Business Context and Reporting Period
This Form 8-K Current Report was filed by NVIDIA Corporation on June 8, 2007. The report addresses "Other Events" (Item 8.01) concerning the formalization and refinement of the company's stock option grant practices during fiscal 2007.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance procedures regarding equity compensation.
Material Changes
The primary material change described is the implementation of written stock option grant procedures approved by the Board of Directors on September 12, 2006. These procedures were designed to enhance the existing grant process through additional approval layers and clarified responsibilities.
Guidance, Outlook, and Management Commentary
Management commentary focuses on the specific mechanics of the new stock option grant procedures:
- Grant Timing: Executive grants are restricted to open trading windows. New employee grants occur on pre-established dates after employment commencement. Semi-annual company-wide awards are scheduled for March and September during open windows.
- Exercise Price: The exercise price is set at the fair market value on the grant date (closing price on the preceding trading day). If the 2007 Equity Incentive Plan is approved by stockholders, the price will be the closing price on the grant date itself.
- Approval Authority: The Compensation Committee approves the annual budget and all grants to executive officers. Limited delegation to management is permitted only within pre-approved guidelines. Grants exceeding two times the guidelines or greater than 5,000 shares require direct Committee approval.
Key Facts for Investor Verification
- Verify the status of the 2007 Equity Incentive Plan approval by stockholders to confirm the applicable exercise price methodology.
- Confirm that all stock option grants since September 12, 2006, have adhered to the documented procedures regarding timing and approval authority.
- Review subsequent filings to ensure no deviations from the pre-established grant dates or trading window restrictions.